ONC Q2 2018 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q2 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$53M

Gross Profit

-$118M-222.9% margin

Operating Income

-$163M-308.8% margin

Net Income

-$157M-297.1% margin

EPS (Diluted)

$-2.86

QoQ Revenue Growth

+62.3%

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$128M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$427M

Stockholders' Equity

$1.2B

Cash & Equivalents

$438M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$0	—
Gross Profit	-$118M	-$47M	-149.1%
Operating Income	-$163M	-$58M	-181.0%
Net Income	-$157M	-$61M	-159.1%